High-throughput in vitro profiling assays: lessons learnt from experiences at Novartis.

Expert Opin Drug Metab Toxicol 2006 Dec;2(6):823-33

Novartis Institutes for BioMedical Research, Basel, Switzerland.

This article reviews the use of a selection of in vitro assays implemented at Novartis and intends to address exposure and safety in early drug discovery. The authors' own experience, based on a large number of 'real' drug discovery compounds, is described to reflect on what has worked, where improvement is needed and how to best use the data for decision making. Possible strategies are discussed, and guidelines are provided on how to organise assays, extract value and contribute knowledge from the data.

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2.6.823DOI Listing
December 2006
3 Citations
2.830 Impact Factor

Publication Analysis

Top Keywords

drug discovery
8
discovery compounds
4
number 'real'
4
'real' drug
4
compounds described
4
reflect worked
4
described reflect
4
large number
4
based large
4
safety early
4
exposure safety
4
early drug
4
discovery authors'
4
authors' experience
4
worked improvement
4
improvement needed
4
organise assays
4
provided organise
4
assays extract
4
extract contribute
4

Similar Publications